NCT00901225 · ADVERSE EVENTS
Adverse events
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
Adverse events occurred during the study; they are not necessarily caused by treatment. Serious events are not interchangeable with severe/grade 3–4 events. These safety populations may differ from efficacy populations.
- Collection time frame
- Not reported
- Other-event reporting threshold
- 5%
| Safety group | Serious events | Other events | Deaths |
|---|---|---|---|
| G-CSF Plus Plerixafor | 0 / 21 | 4 / 21 | Not reported / Not reported |
Serious adverse events
Other reported adverse events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- fever of unknown origin without clinically or microbiologically documented infection)(ANC \<1.0 x 10e9/L, fever \>=38.5 degrees C
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 6
- term
- Febrile neutropenia
Complete source fields
- event Groups
- description
- Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.
- id
- EG000
- other Num Affected
- 4
- other Num At Risk
- 21
- serious Num Affected
- 0
- serious Num At Risk
- 21
- title
- G-CSF Plus Plerixafor
- frequency Threshold
- 5
- other Events
- assessment Type
- SYSTEMATIC_ASSESSMENT
- notes
- fever of unknown origin without clinically or microbiologically documented infection)(ANC \<1.0 x 10e9/L, fever \>=38.5 degrees C
- organ System
- Blood and lymphatic system disorders
- stats
- group Id
- EG000
- num Affected
- 4
- num At Risk
- 21
- num Events
- 6
- term
- Febrile neutropenia
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle